Presentation is loading. Please wait.

Presentation is loading. Please wait.

Inhaled amiloride and tobramycin solutions fail to eradicate Burkholderia dolosa in patients with cystic fibrosis  Ahmet Z. Uluer, David A. Waltz, Leslie.

Published byNuray Akagündüz Modified over 5 years ago

Similar presentations

Presentation on theme: "Inhaled amiloride and tobramycin solutions fail to eradicate Burkholderia dolosa in patients with cystic fibrosis  Ahmet Z. Uluer, David A. Waltz, Leslie."— Presentation transcript:

1 Inhaled amiloride and tobramycin solutions fail to eradicate Burkholderia dolosa in patients with cystic fibrosis  Ahmet Z. Uluer, David A. Waltz, Leslie A. Kalish, Summer Adams, Craig Gerard, Dawn A. Ericson  Journal of Cystic Fibrosis  Volume 12, Issue 1, Pages (January 2013) DOI: /j.jcf Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

2 Fig. 1 Mean percent predicted FEV1 before and after start of treatment in patients enrolled in the trial (or corresponding “baseline” date in non-amiloride cohort). Error bars are ±1 SE. Estimates and SEs are based on a random effects model [9]. Journal of Cystic Fibrosis  , 54-59DOI: ( /j.jcf ) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Download ppt "Inhaled amiloride and tobramycin solutions fail to eradicate Burkholderia dolosa in patients with cystic fibrosis  Ahmet Z. Uluer, David A. Waltz, Leslie."

Similar presentations

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,
Use of high-dose ibuprofen in a pediatric cystic fibrosis center

Use of high-dose ibuprofen in a pediatric cystic fibrosis center
William G. Flight, Jonathan Shaw, Susan Johnson, A

William G. Flight, Jonathan Shaw, Susan Johnson, A
Felix Ratjen, Paul Koker, David E

Felix Ratjen, Paul Koker, David E
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 

How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
H. Grasemann, E. Tullis, F. Ratjen  Journal of Cystic Fibrosis 

H. Grasemann, E. Tullis, F. Ratjen  Journal of Cystic Fibrosis 
Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H

Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H
Single high-dose oral vitamin D3 (stoss) therapy — A solution to vitamin D deficiency in children with cystic fibrosis?  Darren Shepherd, Yvonne Belessis,

Single high-dose oral vitamin D3 (stoss) therapy — A solution to vitamin D deficiency in children with cystic fibrosis?  Darren Shepherd, Yvonne Belessis,
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 

Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.

Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 

Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of.

Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of.
Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection 

Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection 
John Widger, Sarath Ranganathan, Philip J. Robinson 

John Widger, Sarath Ranganathan, Philip J. Robinson 
The ease of breathing test tracks clinical changes in cystic fibrosis

The ease of breathing test tracks clinical changes in cystic fibrosis
Pulmonary exacerbations in CF patients with early lung disease

Pulmonary exacerbations in CF patients with early lung disease
The application of current lifetable methods to compare cystic fibrosis median survival internationally is limited  Abaigeal D. Jackson, Leslie Daly,

The application of current lifetable methods to compare cystic fibrosis median survival internationally is limited  Abaigeal D. Jackson, Leslie Daly,
A cohort study of the Copenhagen CF Centre eradication strategy against Staphylococcus aureus in patients with CF  Christina Schjellerup Dalbøge, Tacjana.

A cohort study of the Copenhagen CF Centre eradication strategy against Staphylococcus aureus in patients with CF  Christina Schjellerup Dalbøge, Tacjana.

Similar presentations

Ads by Google